3 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Thymus Extracts: new trials by email Literature Review of Thymus Extracts trials Research Report on Thymus Extracts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Thymus Transplantation With Immunosuppression #950 Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Switzerland GmbH | 14 | 2005-12-19 | 2022-03-25 |
| Parathyroid and Thymus Transplantation in DiGeorge #931 Thymus/Parathyroid Transplantation - DiGeorge Syndrome, Hypoparathyroidism | Phase 1 | Completed | Sumitomo Pharma Switzerland GmbH | 25 | 2005-01-01 | 2022-04-04 |
| Thymus Transplantation Dose in DiGeorge #932 Cultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation - DiGeorge Anomaly, DiGeorge Syndrome | Phase 2 | Completed | Sumitomo Pharma Switzerland GmbH | 7 | 2004-09-02 | 2022-03-25 |
DiGeorge Syndrome (3) · Hypoparathyroidism (3) · Thymic aplasia (3) · Hypocalcemia (2) · Immunologic Deficiency Syndromes (2)
Sumitomo Pharma Switzerland GmbH (3)
United States (3)
M. Louise Markert, MD, PhD (3)
PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 17284531, PMID 15100156, PMID 21565561, PMID 23607606, PMID 23914737
K12HD043494 (3), R01AI047040 (3), R01AI054843 (3), R56AI047040 (2)